GV Pharma Ltd

1 May 2021 false No description of principal activity Taxfiler 2022.12 11299513business:PrivateLimitedCompanyLtd2021-05-012022-04-30 112995132021-04-30 112995132021-05-012022-04-30 11299513business:AuditExempt-NoAccountantsReport2021-05-012022-04-30 11299513business:AbridgedAccounts2021-05-012022-04-30 112995132022-04-30 11299513business:Director12021-05-012022-04-30 11299513business:RegisteredOffice2021-05-012022-04-30 112995132021-04-30 11299513core:WithinOneYear2022-04-30 11299513core:WithinOneYear2021-04-30 11299513core:AfterOneYear2022-04-30 11299513core:AfterOneYear2021-04-30 11299513core:SharePremium2022-04-30 11299513core:SharePremium2021-04-30 11299513core:RetainedEarningsAccumulatedLosses2022-04-30 11299513core:RetainedEarningsAccumulatedLosses2021-04-30 11299513business:SmallEntities2021-05-012022-04-30 11299513countries:EnglandWales2021-05-012022-04-30 112995132020-05-012021-04-30 iso4217:GBP xbrli:pure
Company Registration No. 11299513 (England and Wales)
GV Pharma Ltd Unaudited accounts for the year ended 30 April 2022
GV Pharma Ltd Unaudited accounts Contents
Page
- 2 -
GV Pharma Ltd Company Information for the year ended 30 April 2022
Director
Gerald Banda
Company Number
11299513 (England and Wales)
Registered Office
STUDIO 5 RIVERSIDE STUDIOS MILL LANE DRONFIELD DERBYSHIRE S18 2XL
- 3 -
GV Pharma Ltd Statement of financial position as at 30 April 2022
2022 
2021 
Notes
£ 
£ 
Current assets
Debtors
- 
1,624 
Cash at bank and in hand
- 
2,008 
- 
3,632 
Creditors: amounts falling due within one year
- 
(11,870)
Net current liabilities
- 
(8,238)
Total assets less current liabilities
- 
(8,238)
Creditors: amounts falling due after more than one year
(8,238)
- 
Net liabilities
(8,238)
(8,238)
Capital and reserves
Share premium
100 
100 
Profit and loss account
(8,338)
(8,338)
Shareholders' funds
(8,238)
(8,238)
For the year ending 30 April 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The members have agreed to the preparation of abridged accounts for the year in accordance with Section 444(2A).
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 30 January 2023 and were signed on its behalf by
Gerald Banda Director Company Registration No. 11299513
- 4 -
GV Pharma Ltd Notes to the Accounts for the year ended 30 April 2022
1
Statutory information
GV Pharma Ltd is a private company, limited by shares, registered in England and Wales, registration number 11299513. The registered office is STUDIO 5 RIVERSIDE STUDIOS, MILL LANE, DRONFIELD, DERBYSHIRE, S18 2XL.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
4
Average number of employees
During the year the average number of employees was 1 (2021: 1).
- 5 -